FDA Inspection 976404 — Sciregs
The FDA completed an inspection of Sciregs on Mar 1, 2016 in Columbia, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 1, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Columbia, MD (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)